Disc Medicine IRON Proceeds From Sale Of Pre Funded Warrants In Underwritten Offerings Net Of Issuance Costs Paid
Proceeds From Sale Of Pre Funded Warrants In Underwritten Offerings Net Of Issuance Costs Paid at other companies
Other financials
Where this comes from
Reported directly by Disc Medicine in its filing.
Tagged under the XBRL concept iron:ProceedsFromSaleOfPreFundedWarrantsInUnderwrittenOfferingsNetOfIssuanceCostsPaid.
The official record: Disc Medicine’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Disc Medicine's proceeds from sale of pre funded warrants in underwritten offerings net of issuance costs paid.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Disc Medicine's proceeds from sale of pre funded warrants in underwritten offerings net of issuance costs paid?
- Disc Medicine (IRON) reported proceeds from sale of pre funded warrants in underwritten offerings net of issuance costs paid of $0 in Q1 2026.
- How has Disc Medicine's proceeds from sale of pre funded warrants in underwritten offerings net of issuance costs paid changed year-over-year?
- Disc Medicine's proceeds from sale of pre funded warrants in underwritten offerings net of issuance costs paid decreased by 100.0% year-over-year, from $9.39M to $0.
- What does proceeds from sale of pre funded warrants in underwritten offerings net of issuance costs paid mean?
- This represents the net cash proceeds from the sale of pre-funded warrants, which are equity-like instruments that allow holders to purchase common stock at a nominal exercise price. These are often used in financing rounds to provide immediate capital while deferring the issuance of common shares. It reflects the company's strategy for raising capital through structured equity instruments.